Navigation Links
TechniScan's CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
Date:2/7/2011

king statements:

Forward-Looking Statements Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "potential," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of TechniScan, Inc. (the "company") to be materially different from those expressed or implied by such forward-looking statements. The company's future operating results are dependent upon many factors, including risk factors discussed in the company's periodic filings with the Securities and Exchange Commission, which are available for review at www.sec.gov, including the company's Annual Report on Form 10-K filed on March 22, 2010. The company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE TechniScan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
3. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
4. Threshold to Host Conference Call to Discuss Results From Clinical Presentations at European Cancer Conference (ECCO)
5. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
6. Spectrum Pharmaceuticals Announces Presentation of SPI-1620 Data at the AACR-NCI-EORTC International Conference
7. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
8. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
9. IDM Pharma Announces Upcoming Clinical Data Presentations
10. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
11. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014  Perrigo Company (NYSE: PRGO ... AB therapeutic equivalent rating from the U.S. Food and ... Application (NDA) for testosterone gel 1.0%. FDA concluded that ... 1% and can be substituted with the full expectation ... safety profile as AndroGel 1% when used under the ...
(Date:7/24/2014)... , July 24, 2014 Talyst, a ... the 2014 National Association of State Veterans Homes (NASVH) ... . The goal of the NASVH is to ensure ... benefits, services, long term health care and respect which ... With the InSite® Remote Dispensing System, Talyst ...
(Date:7/24/2014)... July 24, 2014  Lazarus Effect, a medical ... interventional devices to facilitate removal of blood clots, ... Trademark Office has issued a new patent (U.S. ... company,s Lazarus Cover TM and ReCover TM ... is a single-component stent-retriever (stentriever) with an integrated, ...
Breaking Medicine Technology:Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2
... evaluate, clinical utility of protein biomarkers for predicting treatment ... ... Conn., Sept. 4 HistoRx, Inc., announced,today that it has ... (RTOG), a National Cancer Institute-funded clinical,cooperative group. Under the terms ...
... - ViziLite Plus with TBlue630 -, PHOENIX, Sept. ... with Tblue630(TM) screening system for early detection of,abnormalities which ... identify,pre-cancerous lesions in a Phase II study of Cetuximab ... developed by ImClone,Systems (Nasdaq: IMCL ) and distributed ...
Cached Medicine Technology:HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 2HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 3Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 2Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 3
(Date:7/24/2014)... products at the same rate as adults in the ... Center for Healthy Neighborhoods (PRCHN) at Case Western Reserve ... in five high school students, report use of any ... surprising is that ninth- through twelfth- graders are smoking ... matching a national trend. More students report cigar ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July 24, 2014 (HealthDay ... program for the poor, visit the emergency room for medical ... a U.S. survey finds. And kids with Medicaid were ... a reason other than a serious medical problem, according to ... Control and Prevention. Reliance on ER care ...
(Date:7/24/2014)... - Aristotle said, "Love is composed of a single ... that you and your partner were made in heaven ... new study. , Psychologists observe that people talk ... underlying such diversity are some common themes that frame ... frame considers love as perfect unity ("made for each ...
(Date:7/24/2014)... The South American air and missile defense radar market ... expected to register a CAGR of 9.64% to reach $340 ... security issues like drug trafficking. Brazil is the only market ... and missile defense radar market. This is followed by Argentina ... for radar systems in terms of costal surveillance and other ...
(Date:7/24/2014)... 2014 Dr. Kwame Bawuah Edusei, a ... with an admonition to the youth to persevere in ... He also advised the youth to stay away from ... said, “This workshop will afford you the opportunity of ... withstand the storms in your career path.” Professionals in ...
Breaking Medicine News(10 mins):Health News:Cuyahoga County high school students smoking at the same rate as adults 2Health News:Cuyahoga County high school students smoking at the same rate as adults 3Health News:Cuyahoga County high school students smoking at the same rate as adults 4Health News:Many Kids With Medicaid Use ER as Doctor's Office: CDC 2Health News:Many Kids With Medicaid Use ER as Doctor's Office: CDC 3Health News:New research: When it hurts to think we were made for each other 2Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 2Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 3Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 4Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 5Health News:Youth and Professionals Interact at Washington Metro Area Career Workshop Hosted by the Edusei Foundation 2
... March 17 Researchers will unveil a,new ... been shown in numerous,published studies to help ... the performance of daily living tasks essential ... Corporation, a San,Francisco-based neuroscience company, will introduce ...
... is the Largest Prospective Trial to Examine Asthma Outcomes Based on ... ... N.C. and PHILADELPHIA, March 16 ,Data presented today by GlaxoSmithKline showed ... in asthma patients did not,lead to different responses to Advair Diskus(R) ...
... is the daily,"Profile America" feature from the U.S. Census ... Profile America -- Saturday, March 15th. If you,re ... it,s time to pause,stand back and reflect that there ... events celebrating the value of laughter and those who ...
... Coronary Heart Disease, WASHINGTON, March 14 ... the decision by the Centers,for Medicare and Medicaid ... coverage,for cardiac computed tomographic angiography (CTA) for the ... its national coverage decision for this important,tool for ...
... (March 13, 2008) The American Academy of Cosmetic ... its 2007 Procedural Data. This information is collected by ... that sclerotherapy, the standard treatment for spider and varicose ... surgical procedure, due in large part to men. ...
... found it made difference when disease moved from colon, ... certain patients with cancer that has spread to the ... surgery combined with a special kind of chemotherapy can ... The findings are from one of two Wake Forest ...
Cached Medicine News:Health News:New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 2Health News:New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 3Health News:GSK Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile 2Health News:GSK Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile 3Health News:GSK Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile 4Health News:SCAI Applauds CMS Decision to Continue Coverage of Cardiac CT Scans 2Health News:Combo Treatment Ups Survival When Cancer Spreads to Abdominal Lining 2
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
Indirect hemagglutination test for the qualitative and quantitative determination of antibodies to Toxoplasma gondii in serum....
... Rapid Plasma Reagin ... rapid detection and quantitative ... serum or plasma. Uses ... to detect reagin. Kits ...
Latex agglutination slide test for the qualitative and quantitative detection of rubella virus antibody in serum....
Medicine Products: